OR WAIT null SECS
© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
September 26, 2022
In a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.
September 23, 2022
How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?
September 14, 2022
The underlying neural mechanisms identified may help clinicians better understand ketamine response in human patients.
August 29, 2022
This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.
August 26, 2022
Numinus' Chief Clinical Officer shares resources about the potential use of ketamine in psychiatry.
August 25, 2022
The first patient has been dosed in the phase 2b dose-optimization trial of a pharmaceutically optimized form of LSD for the treatment of generalized anxiety disorder.
August 23, 2022
This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."
August 22, 2022
One researcher shares his evidence for the usage of psilocybin in psychiatry.
August 18, 2022
The resistance against "magic mushrooms"—is it justified?
August 11, 2022
We have an urgent need for new and improved treatment options for depression—are psychedelic medications the answer?